Pub Date : 2025-06-17DOI: 10.1016/j.jhqr.2025.101150
S. Cinaroglu , B. Saylan , S. Zararsız
Objectives
Enhancing the quality of critical care services requires a comprehending of the elements that contribute to their efficiency. This study proposes a new way of understanding of cancer service quality and efficiency from oncology professionals’ perspective by combining crisp and stochastic DEA techniques blended with a fully ranking DEA–AHP approach.
Methods
Our analysis is based on the analysis of cancer care services efficiency of 81 provinces of Turkey by using indicators of cancer care process, quality of cancer care, general quality of health and cancer care services, development level of provinces, and cancer mortality. Based on the DEA–AHP integrated model with fuzzy AHP weights, provinces located in poor areas are the least efficient in terms of cancer care services. Harmonized crisp and stochastic province-level efficiency analysis serves as a mediator variable to better understand the efficiency of cancer services by using geospatial data in oncology and allows capturing the efficiency dynamics of cancer care.
Results
The study findings highlight that the least efficient provinces for cancer care services are those that are mainly found in underdeveloped areas.
Conclusion
Cancer policy makers and oncology professionals should consider the efficiency dynamics of cancer care which acts as a mediator variable to help better understand the efficiency of cancer services through the use of spatial differences in oncology.
{"title":"Understanding quality and efficiency of cancer care services from oncologist's perspective","authors":"S. Cinaroglu , B. Saylan , S. Zararsız","doi":"10.1016/j.jhqr.2025.101150","DOIUrl":"10.1016/j.jhqr.2025.101150","url":null,"abstract":"<div><h3>Objectives</h3><div>Enhancing the quality of critical care services requires a comprehending of the elements that contribute to their efficiency. This study proposes a new way of understanding of cancer service quality and efficiency from oncology professionals’ perspective by combining crisp and stochastic DEA techniques blended with a fully ranking DEA–AHP approach.</div></div><div><h3>Methods</h3><div>Our analysis is based on the analysis of cancer care services efficiency of 81 provinces of Turkey by using indicators of cancer care process, quality of cancer care, general quality of health and cancer care services, development level of provinces, and cancer mortality. Based on the DEA–AHP integrated model with fuzzy AHP weights, provinces located in poor areas are the least efficient in terms of cancer care services. Harmonized crisp and stochastic province-level efficiency analysis serves as a mediator variable to better understand the efficiency of cancer services by using geospatial data in oncology and allows capturing the efficiency dynamics of cancer care.</div></div><div><h3>Results</h3><div>The study findings highlight that the least efficient provinces for cancer care services are those that are mainly found in underdeveloped areas.</div></div><div><h3>Conclusion</h3><div>Cancer policy makers and oncology professionals should consider the efficiency dynamics of cancer care which acts as a mediator variable to help better understand the efficiency of cancer services through the use of spatial differences in oncology.</div></div>","PeriodicalId":37347,"journal":{"name":"Journal of Healthcare Quality Research","volume":"40 5","pages":"Article 101150"},"PeriodicalIF":1.1,"publicationDate":"2025-06-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144297639","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-06-13DOI: 10.1016/j.jhqr.2025.101147
S. Kaniyil , P. Pavithran , A.K. Arun Krishna , M.C. Rajesh
Background and objectives
Enhancing patient safety in Anaesthesia relies significantly on critical incident reporting and analysis. We did an online web-based survey aiming to evaluate the awareness and practices of our anaesthesiologists on critical incident reporting in India.
Materials and methods
A validated questionnaire was disseminated via online social media platforms to evaluate the awareness and current practices of anaesthesiologists on incident reporting and analysis. Timely reminders were issued to enhance response rates, and data analyzed upon receipt of sufficient responses.
Results
Among the 506 responses received, 60% reported having a workplace incident reporting system. Despite high awareness, a significant majority expressed reluctance to report incidents, citing the fear of blame and shame as a deterrent. The most frequently reported incidents included cardiac arrest and drug errors. Identified contributing factors included inadequate staffing, communication gaps, prolonged work hours, a stressful work environment, and the absence of institutional protocols.
Conclusions
Despite a notable level of awareness regarding critical incident reporting among our anaesthesiologists, apprehensions related to blame and finger-pointing hinder the reporting process. As a uniform reporting system is lacking, formulating a national guideline, and establishing a standard reporting system is the need of the hour.
{"title":"Results of a survey to evaluate awareness and practices of critical incident reported by anaesthesiologists","authors":"S. Kaniyil , P. Pavithran , A.K. Arun Krishna , M.C. Rajesh","doi":"10.1016/j.jhqr.2025.101147","DOIUrl":"10.1016/j.jhqr.2025.101147","url":null,"abstract":"<div><h3>Background and objectives</h3><div>Enhancing patient safety in Anaesthesia relies significantly on critical incident reporting and analysis. We did an online web-based survey aiming to evaluate the awareness and practices of our anaesthesiologists on critical incident reporting in India.</div></div><div><h3>Materials and methods</h3><div>A validated questionnaire was disseminated via online social media platforms to evaluate the awareness and current practices of anaesthesiologists on incident reporting and analysis. Timely reminders were issued to enhance response rates, and data analyzed upon receipt of sufficient responses.</div></div><div><h3>Results</h3><div>Among the 506 responses received, 60% reported having a workplace incident reporting system. Despite high awareness, a significant majority expressed reluctance to report incidents, citing the fear of blame and shame as a deterrent. The most frequently reported incidents included cardiac arrest and drug errors. Identified contributing factors included inadequate staffing, communication gaps, prolonged work hours, a stressful work environment, and the absence of institutional protocols.</div></div><div><h3>Conclusions</h3><div>Despite a notable level of awareness regarding critical incident reporting among our anaesthesiologists, apprehensions related to blame and finger-pointing hinder the reporting process. As a uniform reporting system is lacking, formulating a national guideline, and establishing a standard reporting system is the need of the hour.</div></div>","PeriodicalId":37347,"journal":{"name":"Journal of Healthcare Quality Research","volume":"40 6","pages":"Article 101147"},"PeriodicalIF":1.1,"publicationDate":"2025-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144271165","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-06-09DOI: 10.1016/j.jhqr.2025.101146
P. Cárdenas-Soriano , V.S.H. Múgica , P. Blanco-Hernández , M. Gil-López , G. Rodríguez-Caravaca , A.M. Pedraza-Flechas
Objective
To assess the prevalence of Healthcare-Associated Infections (HAIs) acquired during hospitalization in a long-term care (LTC) hospital during three periods and identify associated factors.
Methods
An observational, cross-sectional study had been conducted in 2019, 2021, and 2023 that included 380 patients. Data collected encompassed demographics, presence of risk factors (pressure sores, catheters, surgery), and HAIs acquired in the current hospitalization. Global and per location HAI was determined, and bivariate and a multiple logistic regression model was constructed to explore the association between the studied variables and infection.
Results
The median age varied depending on the year of the survey between 77 and 80.5 years, and the proportion of female patients increased each edition. Length of stay peaked in 2021 (43.5 days), and risk factors in 2023. HAIs prevalences were 8.4% (2019), 10.7% (2021), and 5.6% (2023). Respiratory tract infection was the most frequent globally (34.4%), in 2019 (35.7%) and 2023 (50.0%), followed by urinary tract infection. Globally, HAI and any risk factor (OR: 3.8, 95% CI: 1.6–8.8), and pressure sores (OR: 2.4, 95% CI: 1.1–5.2) were associated, this last remained after adjustment (OR: 16.0, 95% CI: 2.5–104.9).
Conclusions
LTC hospitals pose a risk for HAI. Further research on associated factors and preventive strategies is crucial to improve care in this sector.
{"title":"Healthcare-associated infections in a long-term care hospital: A three-year point-prevalence study","authors":"P. Cárdenas-Soriano , V.S.H. Múgica , P. Blanco-Hernández , M. Gil-López , G. Rodríguez-Caravaca , A.M. Pedraza-Flechas","doi":"10.1016/j.jhqr.2025.101146","DOIUrl":"10.1016/j.jhqr.2025.101146","url":null,"abstract":"<div><h3>Objective</h3><div>To assess the prevalence of Healthcare-Associated Infections (HAIs) acquired during hospitalization in a long-term care (LTC) hospital during three periods and identify associated factors.</div></div><div><h3>Methods</h3><div>An observational, cross-sectional study had been conducted in 2019, 2021, and 2023 that included 380 patients. Data collected encompassed demographics, presence of risk factors (pressure sores, catheters, surgery), and HAIs acquired in the current hospitalization. Global and per location HAI was determined, and bivariate and a multiple logistic regression model was constructed to explore the association between the studied variables and infection.</div></div><div><h3>Results</h3><div>The median age varied depending on the year of the survey between 77 and 80.5 years, and the proportion of female patients increased each edition. Length of stay peaked in 2021 (43.5 days), and risk factors in 2023. HAIs prevalences were 8.4% (2019), 10.7% (2021), and 5.6% (2023). Respiratory tract infection was the most frequent globally (34.4%), in 2019 (35.7%) and 2023 (50.0%), followed by urinary tract infection. Globally, HAI and any risk factor (OR: 3.8, 95% CI: 1.6–8.8), and pressure sores (OR: 2.4, 95% CI: 1.1–5.2) were associated, this last remained after adjustment (OR: 16.0, 95% CI: 2.5–104.9).</div></div><div><h3>Conclusions</h3><div>LTC hospitals pose a risk for HAI. Further research on associated factors and preventive strategies is crucial to improve care in this sector.</div></div>","PeriodicalId":37347,"journal":{"name":"Journal of Healthcare Quality Research","volume":"40 6","pages":"Article 101146"},"PeriodicalIF":1.1,"publicationDate":"2025-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144243553","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-06-09DOI: 10.1016/j.jhqr.2025.101148
M. Vaccaro , G. Polito , G. Bagaglini , M. Capuozzo , R. Langella , E. Nava , A. Zovi , F. Ferrara
Background
Biosimilar drugs represent a valuable opportunity for healthcare systems worldwide, offering substantial cost savings while ensuring equivalent efficacy and safety in treating chronic conditions. These savings can be reinvested in ongoing medical innovation.
Methods
An investigation was carried out to evaluate the utilization of key biologic therapies across various clinical indications within two Italian healthcare institutions: Asl Napoli 3 Sud and Policlinico Umberto I in Rome. Information regarding consumption and expenditure was extracted from institutional databases. A comparison with figures from 2021 was conducted to detect any growth in biosimilar adoption throughout 2022.
Results
The 2022 review demonstrated that most of the examined compounds were administered predominantly as biosimilars, with proportions nearing complete substitution, aside from some notable outliers. In particular, reluctance persisted in prescribing biosimilar adalimumab (73.8%) and etanercept (73.3%) at Asl Napoli 3 Sud, as well as erythropoietin (69.5%) and rituximab (72.8%) at Policlinico Umberto I.
Conclusion
The year-on-year comparison between 2021 and 2022 underscored a growing shift toward biosimilar prescriptions. This favorable direction indicates the likelihood of reaching full implementation soon, with meaningful advantages for the National Healthcare Service and citizens, promoting an efficient and economically viable model of care.
生物仿制药为全球医疗保健系统提供了一个宝贵的机会，在确保治疗慢性疾病的同等功效和安全性的同时，提供了大量的成本节约。这些节省下来的资金可以再投资于正在进行的医疗创新。方法开展一项调查，评估两家意大利医疗机构（那不勒斯3 Sud医院和罗马Umberto I医院）在各种临床适应症中关键生物疗法的使用情况。有关消费和支出的资料摘自机构数据库。与2021年的数据进行比较，以检测整个2022年生物仿制药采用的增长情况。结果2022年的审查表明，除了一些显著的异常值外，大多数被检查的化合物主要作为生物类似药给药，比例接近完全替代。特别是，在Asl Napoli 3 Sud，不愿开生物仿制药阿达木单抗（73.8%）和依那西普（73.3%），以及在Policlinico Umberto i，不愿开促红细胞生成素（69.5%）和利妥昔单抗（72.8%）。结论2021年和2022年的同比比较表明，越来越多的人转向开生物仿制药。这一有利的方向表明，很快就有可能全面实施，对国家医疗保健服务和公民有意义的好处，促进一种高效和经济上可行的护理模式。
{"title":"Comparison and analysis of biological drug consumption in two Italian hospital settings: Governance actions and prescribing appropriateness","authors":"M. Vaccaro , G. Polito , G. Bagaglini , M. Capuozzo , R. Langella , E. Nava , A. Zovi , F. Ferrara","doi":"10.1016/j.jhqr.2025.101148","DOIUrl":"10.1016/j.jhqr.2025.101148","url":null,"abstract":"<div><h3>Background</h3><div>Biosimilar drugs represent a valuable opportunity for healthcare systems worldwide, offering substantial cost savings while ensuring equivalent efficacy and safety in treating chronic conditions. These savings can be reinvested in ongoing medical innovation.</div></div><div><h3>Methods</h3><div>An investigation was carried out to evaluate the utilization of key biologic therapies across various clinical indications within two Italian healthcare institutions: Asl Napoli 3 Sud and Policlinico Umberto I in Rome. Information regarding consumption and expenditure was extracted from institutional databases. A comparison with figures from 2021 was conducted to detect any growth in biosimilar adoption throughout 2022.</div></div><div><h3>Results</h3><div>The 2022 review demonstrated that most of the examined compounds were administered predominantly as biosimilars, with proportions nearing complete substitution, aside from some notable outliers. In particular, reluctance persisted in prescribing biosimilar adalimumab (73.8%) and etanercept (73.3%) at Asl Napoli 3 Sud, as well as erythropoietin (69.5%) and rituximab (72.8%) at Policlinico Umberto I.</div></div><div><h3>Conclusion</h3><div>The year-on-year comparison between 2021 and 2022 underscored a growing shift toward biosimilar prescriptions. This favorable direction indicates the likelihood of reaching full implementation soon, with meaningful advantages for the National Healthcare Service and citizens, promoting an efficient and economically viable model of care.</div></div>","PeriodicalId":37347,"journal":{"name":"Journal of Healthcare Quality Research","volume":"40 6","pages":"Article 101148"},"PeriodicalIF":1.1,"publicationDate":"2025-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144243489","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-06-09DOI: 10.1016/j.jhqr.2025.101149
M. Santiñà Vila , D. Juvinyà Canal
{"title":"Salutogénesis en vez de patogénesis, ¿estamos realizando la necesaria transformación del modelo de sistema de salud?","authors":"M. Santiñà Vila , D. Juvinyà Canal","doi":"10.1016/j.jhqr.2025.101149","DOIUrl":"10.1016/j.jhqr.2025.101149","url":null,"abstract":"","PeriodicalId":37347,"journal":{"name":"Journal of Healthcare Quality Research","volume":"40 6","pages":"Article 101149"},"PeriodicalIF":1.1,"publicationDate":"2025-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144243554","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-05-30DOI: 10.1016/j.jhqr.2025.101141
A. Jain , N.D. Bhardwaj , M. Suhaib , P. Srivastava , S. Khan , S. Rawat
Background
Access to essential medicines is vital for healthcare. The National List of Essential Medicines (NLEM) 2022 serves a guide for Indian healthcare facilities in procuring and providing essential medicines at different levels of healthcare. This study aimed at assessing the compliance of essential medicines availability at a tertiary care government hospital.
Methods
This cross-sectional study was conducted over a period of 24 weeks to assess the availability of essential medicines via reviewing of documents and content analysis. One-Sample Proportion Z-Test (two-tailed) was used to statistically test the result. Z-score was calculated and statistical significance of result was checked. The compliance for various categories as per NLEM 2022 was analyzed and an overall compliance was calculated.
Results
The hospital procured 85.4% (328/384) of NLEM 2022 drugs. Based on the One-Sample Proportion Z-Test, calculated Z-score was 2.65 with 95% confidence interval which indicates the hospital's procurement rate of 85.4% is significantly higher than the expected WHO benchmark of 80%. A total of 18 NLEM sections had ≥80% compliance, with eight sections reached full compliance. However, gaps existed in sections like antidotes, diagnostic agents and dermatological medicines.
Conclusion
In comparison with earlier studies from India, the tertiary care hospital under study has shown better adherence to NLEM 2022 guidelines but there are still some gaps. By addressing the gaps, hospital can continuously improve healthcare delivery, ensure patient safety, and adapt to evolving health challenges, ultimately ensuring high-quality patient care.
{"title":"Conformance to the National List of Essential Medicines 2022 in a government tertiary care hospital","authors":"A. Jain , N.D. Bhardwaj , M. Suhaib , P. Srivastava , S. Khan , S. Rawat","doi":"10.1016/j.jhqr.2025.101141","DOIUrl":"10.1016/j.jhqr.2025.101141","url":null,"abstract":"<div><h3>Background</h3><div>Access to essential medicines is vital for healthcare. The National List of Essential Medicines (NLEM) 2022 serves a guide for Indian healthcare facilities in procuring and providing essential medicines at different levels of healthcare. This study aimed at assessing the compliance of essential medicines availability at a tertiary care government hospital.</div></div><div><h3>Methods</h3><div>This cross-sectional study was conducted over a period of 24 weeks to assess the availability of essential medicines via reviewing of documents and content analysis. One-Sample Proportion <em>Z</em>-Test (two-tailed) was used to statistically test the result. <em>Z</em>-score was calculated and statistical significance of result was checked. The compliance for various categories as per NLEM 2022 was analyzed and an overall compliance was calculated.</div></div><div><h3>Results</h3><div>The hospital procured 85.4% (328/384) of NLEM 2022 drugs. Based on the One-Sample Proportion <em>Z</em>-Test, calculated <em>Z</em>-score was 2.65 with 95% confidence interval which indicates the hospital's procurement rate of 85.4% is significantly higher than the expected WHO benchmark of 80%. A total of 18 NLEM sections had ≥80% compliance, with eight sections reached full compliance. However, gaps existed in sections like antidotes, diagnostic agents and dermatological medicines.</div></div><div><h3>Conclusion</h3><div>In comparison with earlier studies from India, the tertiary care hospital under study has shown better adherence to NLEM 2022 guidelines but there are still some gaps. By addressing the gaps, hospital can continuously improve healthcare delivery, ensure patient safety, and adapt to evolving health challenges, ultimately ensuring high-quality patient care.</div></div>","PeriodicalId":37347,"journal":{"name":"Journal of Healthcare Quality Research","volume":"40 6","pages":"Article 101141"},"PeriodicalIF":1.1,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144170143","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-05-20DOI: 10.1016/j.jhqr.2025.101145
A.M. Al Jaber , A.A.M. Shaheen , A. Albarrati , A.S. Alqahtani , R.F.M. Gwada , H. Alay
Aim
This study aimed to translate and cross-culturally adapt the Self Care of Coronary Heart Disease (CHD) Inventory into Arabic and measure its psychometric properties among Arabic-speaking patients with CHD.
Method
Using Sousa's guidelines on translation, the study assesses the content validity, construct validity, internal consistency, and test–retest reliability of the Arabic version of the Self-Care of Coronary Heart Inventory (SC-CHDI-Ar). A total of 181 patients with CHD were involved in the validity and reliability testing, and a test re-test was conducted with 61 patients at cardiology clinics in Riyadh, Saudi Arabia.
Results
The content validity index of the three subscales of SC-CHDI-Ar was acceptable. Additionally, the SC-CHDI-Ar did not have any floor or ceiling effects. Positive significant correlations were found among the subscales of SC-CHDI-Ar with the Arabic Cardiac Self Efficacy Questionnaire (CSEQ-A) scores. The internal consistency of SC-CHDI-Ar were ranged from (α = 0.70 to 0.95), and the test–retest of the maintenance, management, and confidence subscales were ICC2,1 = 0.86 (95%CI; .70–0.91), 0.76 (95%CI; 0.59–0.85), and 0.76 (95%CI; 0.56– 0.85), respectively.
Conclusion
The SC-CHDII-Ar is an understandable, valid, and reliable instrument for determining the self-care needs of patients with CHD in Saudi Arabia.
{"title":"Cross-cultural adaptation and validation of the Arabic version of self-care of coronary heart disease inventory","authors":"A.M. Al Jaber , A.A.M. Shaheen , A. Albarrati , A.S. Alqahtani , R.F.M. Gwada , H. Alay","doi":"10.1016/j.jhqr.2025.101145","DOIUrl":"10.1016/j.jhqr.2025.101145","url":null,"abstract":"<div><h3>Aim</h3><div>This study aimed to translate and cross-culturally adapt the Self Care of Coronary Heart Disease (CHD) Inventory into Arabic and measure its psychometric properties among Arabic-speaking patients with CHD.</div></div><div><h3>Method</h3><div>Using Sousa's guidelines on translation, the study assesses the content validity, construct validity, internal consistency, and test–retest reliability of the Arabic version of the Self-Care of Coronary Heart Inventory (SC-CHDI-Ar). A total of 181 patients with CHD were involved in the validity and reliability testing, and a test re-test was conducted with 61 patients at cardiology clinics in Riyadh, Saudi Arabia.</div></div><div><h3>Results</h3><div>The content validity index of the three subscales of SC-CHDI-Ar was acceptable. Additionally, the SC-CHDI-Ar did not have any floor or ceiling effects. Positive significant correlations were found among the subscales of SC-CHDI-Ar with the Arabic Cardiac Self Efficacy Questionnaire (CSEQ-A) scores. The internal consistency of SC-CHDI-Ar were ranged from (<em>α</em> <!-->=<!--> <!-->0.70 to 0.95), and the test–retest of the maintenance, management, and confidence subscales were ICC<sub>2,1</sub> <!-->=<!--> <!-->0.86 (95%CI; .70–0.91), 0.76 (95%CI; 0.59–0.85), and 0.76 (95%CI; 0.56– 0.85), respectively.</div></div><div><h3>Conclusion</h3><div>The SC-CHDII-Ar is an understandable, valid, and reliable instrument for determining the self-care needs of patients with CHD in Saudi Arabia.</div></div>","PeriodicalId":37347,"journal":{"name":"Journal of Healthcare Quality Research","volume":"40 6","pages":"Article 101145"},"PeriodicalIF":1.1,"publicationDate":"2025-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144090505","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-05-16DOI: 10.1016/j.jhqr.2025.101144
M. Miron Rubio , J. Regalado de los Cobos , L. Villegas Bruguera , A. Basterretxea Ozamiz , I. Carrillo Murcia , M. Guilabert Mora , J.J. Mira Solves , M. Santiñà Vila
Introduction and objectives
Home hospitalization has emerged as an effective alternative to traditional hospitalization, especially relevant during the COVID-19 pandemic. However, home hospitalization lacks uniformity in its implementation. This study, conducted by the Spanish Society of Home Hospitalization and the Spanish Society of Healthcare Quality, aims to develop specific quality criteria and an accreditation standard for home hospitalization units.
Materials and methods
The qualitative study, carried out between May 2021 and June 2022, was conducted in 3 phases: literature review, consensus conference, and Delphi technique. The literature review identified existing quality criteria, and the consensus conference defined the areas and dimensions of quality. Using the Delphi technique, 67 national experts refined and reached a consensus on these criteria through 2 rounds of online surveys.
Results
The review identified 240 ideas grouped into 17 categories, and after the consensus conference, 120 initial criteria were proposed, reduced to 54 for the Delphi technique. Finally, 23 quality criteria were agreed upon, 14 considered essential and 9 recommended, covering areas such as accessibility, efficacy, patient safety, integrated care, patient experience, and unit efficiency.
Conclusions
The study provides a consensual quality standard for home hospitalization units in Spain, facilitating self-assessment, accreditation, and continuous improvement. The implementation of these criteria will help standardize home hospitalization, ensure service quality, and promote the expansion of this care model, with the Spanish Society of Home Hospitalization responsible for its dissemination and updating.
{"title":"Criterios y norma de acreditación en calidad para servicios de hospitalización a domicilio: documento de la Sociedad Española de Hospitalización a Domicilio y la Sociedad Española de Calidad Asistencial","authors":"M. Miron Rubio , J. Regalado de los Cobos , L. Villegas Bruguera , A. Basterretxea Ozamiz , I. Carrillo Murcia , M. Guilabert Mora , J.J. Mira Solves , M. Santiñà Vila","doi":"10.1016/j.jhqr.2025.101144","DOIUrl":"10.1016/j.jhqr.2025.101144","url":null,"abstract":"<div><h3>Introduction and objectives</h3><div>Home hospitalization has emerged as an effective alternative to traditional hospitalization, especially relevant during the COVID-19 pandemic. However, home hospitalization lacks uniformity in its implementation. This study, conducted by the Spanish Society of Home Hospitalization and the Spanish Society of Healthcare Quality, aims to develop specific quality criteria and an accreditation standard for home hospitalization units.</div></div><div><h3>Materials and methods</h3><div>The qualitative study, carried out between May 2021 and June 2022, was conducted in 3 phases: literature review, consensus conference, and Delphi technique. The literature review identified existing quality criteria, and the consensus conference defined the areas and dimensions of quality. Using the Delphi technique, 67 national experts refined and reached a consensus on these criteria through 2 rounds of online surveys.</div></div><div><h3>Results</h3><div>The review identified 240 ideas grouped into 17 categories, and after the consensus conference, 120 initial criteria were proposed, reduced to 54 for the Delphi technique. Finally, 23 quality criteria were agreed upon, 14 considered essential and 9 recommended, covering areas such as accessibility, efficacy, patient safety, integrated care, patient experience, and unit efficiency.</div></div><div><h3>Conclusions</h3><div>The study provides a consensual quality standard for home hospitalization units in Spain, facilitating self-assessment, accreditation, and continuous improvement. The implementation of these criteria will help standardize home hospitalization, ensure service quality, and promote the expansion of this care model, with the Spanish Society of Home Hospitalization responsible for its dissemination and updating.</div></div>","PeriodicalId":37347,"journal":{"name":"Journal of Healthcare Quality Research","volume":"40 6","pages":"Article 101144"},"PeriodicalIF":1.1,"publicationDate":"2025-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144071824","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-05-15DOI: 10.1016/j.jhqr.2025.101143
N. Abed , S.C. Buttigieg , C. Feichtinger , P. Sousa , B. Knezevic , S. Tella , E. Srulovici , N. Bessa Vilela , R. Cohen , K. Põlluste , M. Odalović , V. Klemm , R. Strametz , J.J. Mira
Pub Date : 2025-05-14DOI: 10.1016/j.jhqr.2025.101140
L. Del-Valle Quintana , K. Sichieri , S. Secoli
Background and objective
Design Thinking is a user centered methodology used to address problems through innovation. Patient safety is a complex issue within healthcare and remains a global priority. International organizations urge the development of joint strategies to tackle this challenge. The objective was to map the current use of Design Thinking as a methodology to promote patient safety in healthcare settings.
Materials and methods
A scoping review was conducted following the Joanna Briggs Institute guidelines, using indexed databases such as PubMed, CINAHL, WOS, EMBASE, Scopus, Science Direct, PsycINFO, SciELO, and ERIC, as well as grey literature from CAPES and ProQuest journals. The protocol was registered in Open Science Framework. Data were analyzed and summarized narratively.
Results
A total of 55 publications applying Design Thinking in the context of patient safety were included. The six international patient safety goals were addressed, with a focus on effective communication (45%) and medication safety (35%). The study design was not reported in 65% of the cases, and 30% lacked data procedures and analysis. The healthcare team participated in 93% of the studies, while patients were involved in 44%. The most common solutions were mobile applications, software, and dashboards.
Conclusions
Design Thinking is contributing to improvements in patient safety by developing co-designed solutions, particularly in the international patient safety goals of communication and medication safety. However, the lack of a rigorous methodological approach limits the validity and replicability of the results.
{"title":"Design Thinking y su uso para promover la seguridad de los pacientes: revisión de alcance","authors":"L. Del-Valle Quintana , K. Sichieri , S. Secoli","doi":"10.1016/j.jhqr.2025.101140","DOIUrl":"10.1016/j.jhqr.2025.101140","url":null,"abstract":"<div><h3>Background and objective</h3><div>Design Thinking is a user centered methodology used to address problems through innovation. Patient safety is a complex issue within healthcare and remains a global priority. International organizations urge the development of joint strategies to tackle this challenge. The objective was to map the current use of Design Thinking as a methodology to promote patient safety in healthcare settings.</div></div><div><h3>Materials and methods</h3><div>A scoping review was conducted following the Joanna Briggs Institute guidelines, using indexed databases such as PubMed, CINAHL, WOS, EMBASE, Scopus, Science Direct, PsycINFO, SciELO, and ERIC, as well as grey literature from CAPES and ProQuest journals. The protocol was registered in Open Science Framework. Data were analyzed and summarized narratively.</div></div><div><h3>Results</h3><div>A total of 55 publications applying Design Thinking in the context of patient safety were included. The six international patient safety goals were addressed, with a focus on effective communication (45%) and medication safety (35%). The study design was not reported in 65% of the cases, and 30% lacked data procedures and analysis. The healthcare team participated in 93% of the studies, while patients were involved in 44%. The most common solutions were mobile applications, software, and dashboards.</div></div><div><h3>Conclusions</h3><div>Design Thinking is contributing to improvements in patient safety by developing co-designed solutions, particularly in the international patient safety goals of communication and medication safety. However, the lack of a rigorous methodological approach limits the validity and replicability of the results.</div></div>","PeriodicalId":37347,"journal":{"name":"Journal of Healthcare Quality Research","volume":"40 4","pages":"Article 101140"},"PeriodicalIF":1.1,"publicationDate":"2025-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143948760","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
扫码关注我们
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号